Opioid therapy in the treatment of chronic pain conditions in Germany

Background: Primarily used for treating malignant pain, opioids are recently applied for chronic non-tumor pain. For the lack of evidence based strategies from long-term studies, opioids are discussed controversially, esp. considering cost-benefit. Objectives: The purpose of this study is to evaluat...

Full description

Saved in:
Bibliographic Details
Main Authors: Werber, Andreas (Author) , Moradi, Babak (Author) , Schiltenwolf, Marcus (Author)
Format: Article (Journal)
Language:English
Published: 02-10-2015
In: Pain physician
Year: 2015, Volume: 18, Issue: 3, Pages: E323-331
ISSN:2150-1149
Online Access:Verlag, Volltext: http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=18&page=E323
Get full text
Author Notes:Andreas Werber, MD, Ursula Marschall, MD, Helmut L’hoest, MD, Winfried Hauser, MD, Babak Moradi, MD, and Marcus Schiltenwolf, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1561857963
003 DE-627
005 20220813210237.0
007 cr uuu---uuuuu
008 170808s2015 xx |||||o 00| ||eng c
035 |a (DE-627)1561857963 
035 |a (DE-576)491857969 
035 |a (DE-599)BSZ491857969 
035 |a (OCoLC)1340978004 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Werber, Andreas  |e VerfasserIn  |0 (DE-588)143698389  |0 (DE-627)653857497  |0 (DE-576)338443452  |4 aut 
245 1 0 |a Opioid therapy in the treatment of chronic pain conditions in Germany  |c Andreas Werber, MD, Ursula Marschall, MD, Helmut L’hoest, MD, Winfried Hauser, MD, Babak Moradi, MD, and Marcus Schiltenwolf, MD 
264 1 |c 02-10-2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.08.2017 
520 |a Background: Primarily used for treating malignant pain, opioids are recently applied for chronic non-tumor pain. For the lack of evidence based strategies from long-term studies, opioids are discussed controversially, esp. considering cost-benefit. Objectives: The purpose of this study is to evaluate characteristics in prescribing opioids for tumor and non-tumor pain conditions. Study design: Cost effectiveness study/observational study Setting/Methods: Health insurance data of a German statutory health insurance company (N = 6.800.000, data acquisition from 2006 to 2010) was evaluated by assigning opioid prescriptions to certain pain related diagnoses using CART (Classification And Regression Tree) segmentation analysis. Age- and gender-specific characteristics of prescriptions were calculated. Results: The number of prescriptions of opioid prescriptions increased linearly. Prescriptions of mild opioids were decreasing for non-tumor pain, but increasing for tumor pain, while the number of prescriptions of strong opioids was increasing both for tumor and nontumor pain. Differences occurred in terms of duration and kind of the preferred substances, including the considerations of common contraindications (e.g. somatoform disorders). The majority of strong opioids being prescribed for non-tumor pain were fentanyl pain patches for 40 to 45 year old males with average annual costs of 1833 Euros per patient. Out of 21000 patients with somatoform pain disorder, 44.4% were treated with opioids (20.7% with mild, 23.7% with strong opioids). Limitation: The results did not consider if the opioid medication was actually taken by the patients. Another difference in terms of representativeness might occur since the gender distribution varies between the official statistical data and data collected by the health insurance company. Because of the acquisition of the data, no conclusions about possible correlation of pain syndromes and educational and social classes are possible. Tumor patients who received an opioid prescription for non-tumor pain could not be excluded. Conclusions: While the overall expenditure of the health insurance companies increased, it remains unknown which patient is receiving a particular opioid medication. Prescribing behavior was often not consistent with common indications and contraindications. 
650 4 |a Adult 
650 4 |a Aged 
650 4 |a Analgesics, Opioid 
650 4 |a Chronic Pain 
650 4 |a Female 
650 4 |a fentanyl 
650 4 |a Germany 
650 4 |a Humans 
650 4 |a Insurance, Health 
650 4 |a Male 
650 4 |a Middle Aged 
650 4 |a Pain Management 
650 4 |a Treatment Outcome 
700 1 |a Moradi, Babak  |d 1978-  |e VerfasserIn  |0 (DE-588)133032221  |0 (DE-627)530943786  |0 (DE-576)299577260  |4 aut 
700 1 |a Schiltenwolf, Marcus  |d 1959-  |e VerfasserIn  |0 (DE-588)11138673X  |0 (DE-627)515952303  |0 (DE-576)289700841  |4 aut 
773 0 8 |i Enthalten in  |t Pain physician  |d Paducah, Ky. : Soc., 1999  |g 18(2015), 3, Seite E323-331  |h Online-Ressource  |w (DE-627)515976237  |w (DE-600)2244163-3  |w (DE-576)281315191  |x 2150-1149  |7 nnas  |a Opioid therapy in the treatment of chronic pain conditions in Germany 
773 1 8 |g volume:18  |g year:2015  |g number:3  |g pages:E323-331  |g extent:9  |a Opioid therapy in the treatment of chronic pain conditions in Germany 
856 4 0 |u http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=18&page=E323  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170808 
993 |a Article 
994 |a 2015 
998 |g 11138673X  |a Schiltenwolf, Marcus  |m 11138673X:Schiltenwolf, Marcus  |d 910000  |d 911460  |e 910000PS11138673X  |e 911460PS11138673X  |k 0/910000/  |k 1/910000/911460/  |p 6  |y j 
998 |g 133032221  |a Moradi, Babak  |m 133032221:Moradi, Babak  |d 910000  |d 911460  |e 910000PM133032221  |e 911460PM133032221  |k 0/910000/  |k 1/910000/911460/  |p 5 
998 |g 143698389  |a Werber, Andreas  |m 143698389:Werber, Andreas  |d 910000  |d 911460  |e 910000PW143698389  |e 911460PW143698389  |k 0/910000/  |k 1/910000/911460/  |p 1  |x j 
999 |a KXP-PPN1561857963  |e 2976694540 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Opioid therapy in the treatment of chronic pain conditions in Germany","title":"Opioid therapy in the treatment of chronic pain conditions in Germany"}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"02-10-2015"}],"note":["Gesehen am 08.08.2017"],"id":{"eki":["1561857963"]},"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Andreas Werber, MD, Ursula Marschall, MD, Helmut L’hoest, MD, Winfried Hauser, MD, Babak Moradi, MD, and Marcus Schiltenwolf, MD"]},"relHost":[{"disp":"Opioid therapy in the treatment of chronic pain conditions in GermanyPain physician","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Pain physician","subtitle":"official journal of the American Society of Interventional Pain Physicians","title_sort":"Pain physician"}],"note":["Teils fehlerhafte ISSN: 2150-1159","Gesehen am 02.11.2021"],"pubHistory":["Nachgewiesen 2.1999 -"],"origin":[{"publisherPlace":"Paducah, Ky.","dateIssuedKey":"1999","publisher":"Soc.","dateIssuedDisp":"1999-"}],"id":{"issn":["2150-1149"],"zdb":["2244163-3"],"eki":["515976237"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"515976237","part":{"text":"18(2015), 3, Seite E323-331","issue":"3","pages":"E323-331","year":"2015","volume":"18","extent":"9"},"language":["eng"]}],"recId":"1561857963","person":[{"given":"Andreas","role":"aut","display":"Werber, Andreas","family":"Werber"},{"display":"Moradi, Babak","family":"Moradi","given":"Babak","role":"aut"},{"role":"aut","given":"Marcus","family":"Schiltenwolf","display":"Schiltenwolf, Marcus"}],"language":["eng"]} 
SRT |a WERBERANDROPIOIDTHER0210